|
Epidemiology and Prognosis of COVID-19 Patients in the First to Third Waves of the Epidemic in Southern Fars Province, Iran
|
Razieh Zahedi1   , Maryam Chegeni2 , Vahid Rahmanian *3 |
1- Research Center for Social determinant of Health, Jahrom University of Medical Sciences, Jahrom, IR Iran, Research Center for Social determinant of Health, Jahrom University of Medical Sciences, Jahrom, IR Iran
2- Department of public health, Khomein University of Medical Sciences, Khomein, IR Iran, Department of public health, Khomein University of Medical Sciences, Khomein, IR Iran
3- Department of public health, Torbat Jam Faculty of Medical Sciences, Torbat Jam, IR Iran, Department of public health, Torbat Jam Faculty of Medical Sciences, Torbat Jam, IR Iran , vahid.rahmani1392@gmail.com |
|
|
Abstract: (776 Views) |
Background: Covid-19 epidemic is the most important global health problem. The aim of this study was to compare the epidemiological status waves of Covid-19 in the southern Fars, Iran.
Materials and methods: This descriptive study with secondary data analysis of 47161 outpatients and hospitalized Covid-19 from the Center for Disease Control and Prevention and the Medical Care Monitoring Center (MCMC) of Jahrom University of Medical Sciences from the beginning of March to 2020 to the end of May 2021. During this period, three waves occurred in Jahrom city.
Results: A total of 41421 patients(87.82%) were outpatients and 5740 patients (12.18%) were hospitalized. Most cases in the first and third waves were in the age group of 20-49 years and in the second wave were 50-69 years (p <0.001).The percentage of patients who died in the first to third waves were 8%, 10.4% and 4.1%, respectively(p <0.001). People with high blood pressure (27.9%) and heart disease (21%) are the most hospitalized. In general, the most common clinical symptoms were dyspnea (52.3%), cough(44%) and fever(36.2%). The proportion of patients with po2<93% in all three waves were 33.7%, 47.5% and 32.1%, respectively and the proportion of patients receiving oxygen was 1.6, 56.9 and 42.3%, respectively.
Conclusion: The symptoms of Covid-19 in patients admitted in three waves were not much different and were almost similar in terms of disease severity. The increase in deaths in the second wave is mostly due to differences in age groups or people with underlying diseases.
|
|
| Keywords: Epidemic curve, SARS‑CoV‑2, mutation, Iran |
|
|
Full-Text [PDF 1257 kb]
(279 Downloads)
|
Type of Study: Original |
Subject:
Special
Received: 2023/09/18 | Accepted: 2023/10/14 | Published: 2023/10/21
|
|
|
|
|
|
|
| References |
1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England journal of medicine. 2020;382(8):727-33. [ DOI:10.1056/NEJMoa2001017] 2. Rahmanian V, Rabiee MH, Sharifi H. Case fatality rate of coronavirus disease 2019 (COVID-19) in Iran-a term of caution. Asian Pacific Journal of Tropical Medicine. 2020;13(7):328. [ DOI:10.4103/1995-7645.281617] 3. Read JM, Bridgen JRE, Cummings DAT, Ho A, Jewell CP. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. medRxiv. 2020:2020.01.23.20018549. [ DOI:10.1101/2020.01.23.20018549] 4. Kimball A, Hatfield KM, Arons M, James A, Taylor J, Spicer K, et al. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility-King County, Washington, March 2020. Morbidity and Mortality Weekly Report. 2020;69(13):377. [ DOI:10.15585/mmwr.mm6913e1] 5. Esmaeilzadeh N, Shakeri M, Esmaeilzadeh M, Rahmanian V. ARIMA models forecasting the SARS-COV-2 in the Islamic Republic of Iran. Asian Pacific Journal of Tropical Medicine. 2020;13(11):521. [ DOI:10.4103/1995-7645.291407] 6. Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung S-m, Hayashi K, et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). International journal of infectious diseases. 2020;94:154. [ DOI:10.1016/j.ijid.2020.03.020] 7. Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance. 2020;25(10):2000180. [ DOI:10.2807/1560-7917.ES.2020.25.10.2000180] 8. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The lancet. 2020;395(10223):514-23. [ DOI:10.1016/S0140-6736(20)30154-9] 9. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New England Journal of Medicine. 2020;382(12):1177-9. [ DOI:10.1056/NEJMc2001737] 10. Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, et al. A systematic review of asymptomatic infections with COVID-19. Journal of Microbiology, Immunology and Infection. 2021;54(1):12-6. [ DOI:10.1016/j.jmii.2020.05.001] 11. Wei WE, Li Z, Chiew CJ, Yong SE, Toh MP, Lee VJ. Presymptomatic transmission of SARS-CoV-2-Singapore, january 23-march 16, 2020. Morbidity and Mortality Weekly Report. 2020;69(14):411. [ DOI:10.15585/mmwr.mm6914e1] 12. He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nature Medicine. 2020;26(5):672-5. [ DOI:10.1038/s41591-020-0869-5] 13. Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020;8(5):475-81. [ DOI:10.1016/S2213-2600(20)30079-5] 14. Long C, Xu H, Shen Q, Zhang X, Fan B, Wang C, et al. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? European journal of radiology. 2020;126:108961. [ DOI:10.1016/j.ejrad.2020.108961] 15. Zahedi R, Khorshidsavar H, Rahmanian V, Sharifi N. Accuracy of RT-PCR Test in diagnosing COVID-19: A retrospective Study. Pakistan Journal of Medical and Health Sciences. 2021;15(2):534-8. 16. Karimi F, Vaezi AA, Qorbani M, Moghadasi F, Gelsfid SH, Maghoul A, et al. Clinical and laboratory findings in COVID-19 adult hospitalized patients from Alborz province / Iran: comparison of rRT-PCR positive and negative. BMC Infectious Diseases. 2021;21(1):256. [ DOI:10.1186/s12879-021-05948-5] 17. Leung K, Shum M, Leung G, Lam T, Wu J. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020. Eurosurveillance 26, 2002106. S E Ip Ips R Ias Ias. 2021. [ DOI:10.2807/1560-7917.ES.2020.26.1.2002106] 18. Walensky RP, Walke HT, Fauci AS. SARS-CoV-2 variants of concern in the United States-Challenges and opportunities. Jama. 2021;325(11):1037-8. [ DOI:10.1001/jama.2021.2294] 19. Wang Y, Wu J, Zhang L, Zhang Y, Wang H, Ding R, et al. The Infectivity and Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom. 2021. [ DOI:10.21203/rs.3.rs-153108/v1] 20. Galloway SE, Paul P, MacCannell DR, Johansson MA, Brooks JT, MacNeil A, et al. Emergence of SARS-CoV-2 b. 1.1. 7 lineage-united states, december 29, 2020-january 12, 2021. Morbidity and Mortality Weekly Report. 2021;70(3):95. [ DOI:10.15585/mmwr.mm7003e2] 21. Bartoszko JJ, Siemieniuk RA, Kum E, Qasim A, Zeraatkar D, Ge L, et al. Prophylaxis for covid-19: living systematic review and network meta-analysis. MedRxiv. 2021. 22. Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. Arch Acad Emerg Med. 2020;8(1):e35-e. [ DOI:10.1371/journal.pone.0241265] 23. Javanmardi F, Keshavarzi A, Akbari A, Emami A, Pirbonyeh N. Prevalence of underlying diseases in died cases of COVID-19: A systematic review and meta-analysis. PloS one. 2020;15(10):e0241265. [ DOI:10.1371/journal.pone.0241265] 24. Kompaniyets L, Agathis NT, Nelson JM, Preston LE, Ko JY, Belay B, et al. Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children. JAMA Netw Open [Internet]. 2021 2021/06//; 4(6):[e2111182 p.]. Available from: http://europepmc.org/abstract/MED/34097050
https://doi.org/10.1001/jamanetworkopen.2021.11182 [ DOI:10.1001/jamanetworkopen.2021.11182 https://europepmc.org/articles/PMC8185607.] 25. Jalali SF, Ghassemzadeh M, Mouodi S, Javanian M, Akbari Kani M, Ghadimi R, et al. Epidemiologic comparison of the first and second waves of coronavirus disease epidemics in Babol, North of Iran. Caspian Journal of Internal Medicine. 2020;11(0):544-50. 26. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet. 2020;395(10223):507-13. [ DOI:10.1016/S0140-6736(20)30211-7] 27. Liu S, Zhang M, Yang L, Li Y, Wang L, Huang Z, et al. Prevalence and patterns of tobacco smoking among Chinese adult men and women: findings of the 2010 national smoking survey. J Epidemiol Community Health. 2017;71(2):154-61. [ DOI:10.1136/jech-2016-207805] 28. Dehghani Firouzabadi F, Dehghani Firouzabadi M, Ghalehbaghi B, Jahandideh H, Roomiani M, Goudarzi S. Have the symptoms of patients with COVID-19 changed over time during hospitalization? Medical hypotheses. 2020;143. [ DOI:10.1016/j.mehy.2020.110067] 29. Rahimzadeh P, Amniati S, Farahmandrad R, Faiz SHR, Emami SH, Habibi A. Clinical characteristics of critically Ill patients infected with COVID-19 in Rasoul Akram Hospital in Iran: A Single center study. Anesthesiology and Pain Medicine. 2020;10(5). [ DOI:10.5812/aapm.107211] 30. Karimi F, Vaezi AA, Qorbani M, Moghadasi F, Gelsfid SH, Maghoul A, et al. Clinical and laboratory findings in COVID-19 adult hospitalized patients from Alborz province/Iran: comparison of rRT-PCR positive and negative. BMC Infectious Diseases. 2021;21(1):1-8. [ DOI:10.1186/s12879-021-05948-5] 31. Shahriarirad R, Khodamoradi Z, Erfani A, Hosseinpour H, Ranjbar K, Emami Y, et al. Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran. BMC infectious diseases. 2020;20(1):1-12. [ DOI:10.1186/s12879-020-05128-x] 32. Firouzabadi FD, Firouzabadi MD, Ghalehbaghi B, Jahandideh H, Roomiani M, Goudarzi S. Have the symptoms of patients with COVID-19 changed over time during hospitalization? Medical hypotheses. 2020;143:110067-. [ DOI:10.1016/j.mehy.2020.110067] |
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
|
